AI Analysis

How does CLAZF make money? Does CLAZF have pricing power? What's the Earnings Whisper? Will CLAZF profit more as the business scales? What is CLAZF's management track record? Is CLAZF's current price justified?

Claritas Pharmaceuticals, Inc.

$0 +$0.00 (+0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0 - $0

Year Range

$0 - $0

Market Cap

3.66K

AVG Volume

231

Trailing/Forward PE

0/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-30

Primary Exchange

Other OTC

Revenue (USD) · TTM

CLAZF Revenue (USD) · TTM by quarter
Period	Revenue (USD) · TTM
21 Q3	0
21 Q2	0
21 Q1	0
20 Q4	0
20 Q3	0
20 Q2	0
20 Q1	0
19 Q4	0
19 Q3	0
19 Q2	0

Net Income (USD) · TTM

CLAZF Net Income (USD) · TTM by quarter
Period	Net Income (USD) · TTM
21 Q3	-4.72M
21 Q2	-5.31M
21 Q1	-12.03M
20 Q4	4.21M
20 Q3	-3.62M
20 Q2	-4.18M
20 Q1	-875K
19 Q4	-21.21M
19 Q3	-11.55M
19 Q2	-8.78M

Operating Income (USD) · TTM

CLAZF Operating Income (USD) · TTM by quarter
Period	Operating Income (USD) · TTM
21 Q3	770K
21 Q2	462K
21 Q1	643K
20 Q4	247K
20 Q3	-2.28M
20 Q2	-3.64M
20 Q1	-6.41M
19 Q4	-12.24M
19 Q3	-14.89M
19 Q2	-15.39M

EBITDA (USD) · TTM

CLAZF EBITDA (USD) · TTM by quarter
Period	EBITDA (USD) · TTM
21 Q3	-2.64M
21 Q2	-2.3M
21 Q1	-2.3M
20 Q4	14.4M
20 Q3	7.31M
20 Q2	8M
20 Q1	-2.43M
19 Q4	-20.01M
19 Q3	-5.96M
19 Q2	-10.31M

Cash Flows (USD) · TTM

CLAZF Cash Flows (USD) · TTM by quarter
Period	Cash Flows (USD) · TTM
21 Q3	-953K
21 Q2	-405K
21 Q1	-607K
20 Q4	-309K
20 Q3	20K
20 Q2	-1.36M
20 Q1	-5.67M
19 Q4	-6.48M
19 Q3	-7.15M
19 Q2	-7.2M

EPS (USD) · TTM

CLAZF EPS (USD) · TTM by quarter
Period	EPS (USD) · TTM
21 Q3	-0.16
21 Q2	-0.18
21 Q1	-0.45
20 Q4	0.23
20 Q3	-0.1
20 Q2	-0.12
20 Q1	-0.03
19 Q4	-1.05
19 Q3	-1.27
19 Q2	-1.03

Expenses (USD) · TTM

CLAZF Expenses (USD) · TTM by quarter
Period	Expenses (USD) · TTM
21 Q3	-770K
21 Q2	-448K
21 Q1	-555K
20 Q4	-159K
20 Q3	2.37M
20 Q2	3.71M
20 Q1	6.41M
19 Q4	9.45M
19 Q3	15.92M
19 Q2	16.41M

Shares Outstanding · TTM

CLAZF Shares Outstanding · TTM by quarter
Period	Shares Outstanding · TTM
21 Q3	-241K
21 Q2	60K
21 Q1	-64K
20 Q4	-216K
20 Q3	-519K
20 Q2	-757K
20 Q1	-788K
19 Q4	-925K
19 Q3	-1.01M
19 Q2	-938K

PE Ratio

CLAZF PE Ratio by quarter
Period	PE Ratio
Jun 21	0.07
Jun 21	0.08
Jun 21	0.09
Jun 21	0.11
May 21	0.12
May 21	0.11
May 21	0.1
May 21	0.09
Apr 21	0.11
Apr 21	0.12
Apr 21	0.16
Apr 21	0.11
Apr 21	0.13
Sep 19	0.1
Sep 19	0.1
Sep 19	0.11
Sep 19	0.11
Aug 19	0.12
Aug 19	0.12
Aug 19	0.1
Aug 19	0.11
Aug 19	0.1
Jul 19	0.1
Jul 19	0.11
Jul 19	0.09
Jul 19	0.11
Jun 19	0.03
Jun 19	0.03
Jun 19	0.03
Jun 19	0.03
May 19	0.03
May 19	0.03
May 19	0.02
May 19	0.02
May 19	0.02
Apr 19	0.02
Apr 19	0.03
Apr 19	0.03
Apr 19	0.03

Free Cash Flow Yield

CLAZF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-26912.54%
Sep 26	-26912.54%
Aug 26	-26912.54%
Aug 26	-26912.54%
Aug 26	-26912.54%
Aug 26	-26912.54%
Jul 26	-26912.54%
Jul 26	-26912.54%
Jul 26	-26912.54%
Jul 26	-26912.54%
Jul 26	-26912.54%
Jun 26	-26912.54%
Jun 26	-26912.54%
Jun 26	-26912.54%
Jun 26	-26912.54%
May 26	-26912.54%
May 26	-26912.54%
May 26	-26912.54%
May 26	-26912.54%
May 26	-26912.54%
Apr 26	-26912.54%
Apr 26	-26912.54%
Apr 26	-26912.54%
Apr 26	-26912.54%
Mar 26	-26912.54%
Mar 26	-26912.54%
Mar 26	-26912.54%
Mar 26	-26912.54%
Feb 26	-2691254.13%
Feb 26	-26912.54%
Feb 26	-26912.54%
Feb 26	-26912.54%
Jan 26	-26912.54%
Jan 26	-26912.54%
Jan 26	-26912.54%
Jan 26	-26912.54%
Jan 26	-26912.54%
Dec 25	-26912.54%
Dec 25	-26912.54%
Dec 25	-26912.54%
Dec 25	-26912.54%
Nov 25	-26912.54%
Nov 25	-26912.54%
Nov 25	-26912.54%
Nov 25	-26912.54%
Oct 25	-26912.54%
Oct 25	-26912.54%
Oct 25	-26912.54%
Oct 25	-26912.54%
Oct 25	-26912.54%
Sep 25	-26912.54%
Sep 25	-26912.54%
Sep 25	-26912.54%
Sep 25	-26912.54%
Aug 25	-26912.54%
Aug 25	-26912.54%
Aug 25	-26912.54%
Aug 25	-26912.54%
Aug 25	-26912.54%
Jul 25	-26912.54%
Jul 25	-26912.54%
Jul 25	-26912.54%
Jul 25	-26912.54%
Jun 25	-26912.54%
Jun 25	-26912.54%
Jun 25	-26912.54%
Jun 25	-26912.54%
May 25	-26912.54%
May 25	-26912.54%
Jan 25	-26912.54%
Jan 25	-26912.54%
Jan 25	-26912.54%
Jan 25	-26912.54%
Dec 24	-26912.54%
Dec 24	-2691254.13%
Dec 24	-26912.54%
Dec 24	-26912.54%
Nov 24	-26912.54%
Nov 24	-26912.54%
Nov 24	-269125.41%
Nov 24	-26912.54%
Nov 24	-26912.54%
Oct 24	-2691254.13%
Sep 24	-26912.54%
Sep 24	-26912.54%
Sep 24	-26912.54%
Sep 24	-26912.54%
Aug 24	-26912.54%
Aug 24	-26912.54%
Aug 24	-26912.54%
Aug 24	-26912.54%
Aug 24	-26912.54%
Jul 24	-26912.54%
Jun 24	-26912.54%
May 24	-26912.54%
Apr 24	-26912.54%
Feb 24	-269125.41%
Feb 24	-269125.41%
Jan 24	-269125.41%
Jan 24	-26912.54%

EV/EBITDA

CLAZF EV/EBITDA by quarter
Period	EV/EBITDA
Jun 21	0.08
Jun 21	0.09
Jun 21	0.09
Jun 21	0.09
May 21	0.1
May 21	0.1
May 21	0.09
May 21	0.09
Apr 21	0.1
Apr 21	0.1
Apr 21	0.11
Apr 21	0.1
Apr 21	0.1
Mar 21	0.12
Mar 21	0.13
Mar 21	0.13
Mar 21	0.12
Feb 21	0.14
Feb 21	0.1
Feb 21	0.1
Feb 21	0.1
Jan 21	0.06
Jan 21	0.06
Jan 21	0.06
Jan 21	0.06
Dec 20	0.06
Dec 20	0.12
Dec 20	0.1
Dec 20	0.1
Dec 20	0.1
Nov 20	0.1
Nov 20	0.1
Nov 20	0.1
Nov 20	0.1
Oct 20	0.1
Oct 20	0.1
Oct 20	0.1
Oct 20	0.1
Oct 20	0.1
Jun 19	0.07
Jun 19	0.06
Jun 19	0.07
Jun 19	0.06
May 19	0.07
May 19	0.06
May 19	0.06
May 19	0.05
May 19	0.05
Apr 19	0.06
Apr 19	0.07
Apr 19	0.08
Apr 19	0.08

Price/Operating Cashflow

CLAZF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Mar 21	23.7
Mar 21	27.02
Mar 21	26.75
Mar 21	24.38
Feb 21	30.47
Feb 21	17.13
Feb 21	16.93
Feb 21	14.9
Jan 21	0.68
Jan 21	0.68
Jan 21	0.68
Jan 21	0.68
Dec 20	0.68

Price to Book

CLAZF Price to Book by quarter
Period	Price to Book
Sep 26	0
Sep 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Aug 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jul 26	0
Jun 26	0
Jun 26	0
Jun 26	0
Jun 26	0
May 26	0
May 26	0
May 26	0
May 26	0
May 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Apr 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Mar 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Feb 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Jan 26	0
Dec 25	0
Dec 25	0
Dec 25	0
Dec 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Nov 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Oct 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Sep 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Aug 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jul 25	0
Jun 25	0
Jun 25	0
Jun 25	0
Jun 25	0
May 25	0
May 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Jan 25	0
Dec 24	0
Dec 24	0
Dec 24	0
Dec 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Nov 24	0
Oct 24	0
Sep 24	0
Sep 24	0
Sep 24	0
Sep 24	0
Aug 24	0
Aug 24	0
Aug 24	0
Aug 24	0
Aug 24	0
Jul 24	0
Jun 24	0
May 24	0
Apr 24	0
Feb 24	0
Feb 24	0
Jan 24	0
Jan 24	0

No video analysis for this stock yet. Request one from our team.

AI Analysis

Claritas Pharmaceuticals, Inc.

Video analysis: CLAZF

Similar companies